Global Neurodegenerative Disease Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery

Table of Content

1 Market Overview

• 1.1 Product Definition and Market Characteristics
• 1.2 Global Neurodegenerative Disease Market Size
• 1.3 Market Segmentation
• 1.4 Global Macroeconomic Analysis
• 1.5 SWOT Analysis

2. Market Dynamics

• 2.1 Market Drivers
• 2.2 Market Constraints and Challenges
• 2.3 Emerging Market Trends
• 2.4 Impact of COVID-19
  • 2.4.1 Short-term Impact
  • 2.4.2 Long-term Impact

3 Associated Industry Assessment

• 3.1 Supply Chain Analysis
• 3.2 Industry Active Participants
  • 3.2.1 Suppliers of Raw Materials
  • 3.2.2 Key Distributors/Retailers
• 3.3 Alternative Analysis
• 3.4 The Impact of Covid-19 From the Perspective of Industry Chain

4 Market Competitive Landscape

• 4.1 Industry Leading Players
• 4.2 Industry News
  • 4.2.1 Key Product Launch News
  • 4.2.2 M&A and Expansion Plans

5 Analysis of Leading Companies

• 5.1 Merck and Co. Inc.
  • 5.1.1 Merck and Co. Inc. Company Profile
  • 5.1.2 Merck and Co. Inc. Business Overview
  • 5.1.3 Merck and Co. Inc. Neurodegenerative Disease Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.1.4 Merck and Co. Inc. Neurodegenerative Disease Products Introduction
• 5.2 AbbVie Inc.
  • 5.2.1 AbbVie Inc. Company Profile
  • 5.2.2 AbbVie Inc. Business Overview
  • 5.2.3 AbbVie Inc. Neurodegenerative Disease Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.2.4 AbbVie Inc. Neurodegenerative Disease Products Introduction
• 5.3 Amneal Pharmaceuticals Inc.
  • 5.3.1 Amneal Pharmaceuticals Inc. Company Profile
  • 5.3.2 Amneal Pharmaceuticals Inc. Business Overview
  • 5.3.3 Amneal Pharmaceuticals Inc. Neurodegenerative Disease Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.3.4 Amneal Pharmaceuticals Inc. Neurodegenerative Disease Products Introduction
• 5.4 Teva Pharmaceutical
  • 5.4.1 Teva Pharmaceutical Company Profile
  • 5.4.2 Teva Pharmaceutical Business Overview
  • 5.4.3 Teva Pharmaceutical Neurodegenerative Disease Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.4.4 Teva Pharmaceutical Neurodegenerative Disease Products Introduction
• 5.5 F. Hoffmann-La Roche Ltd
  • 5.5.1 F. Hoffmann-La Roche Ltd Company Profile
  • 5.5.2 F. Hoffmann-La Roche Ltd Business Overview
  • 5.5.3 F. Hoffmann-La Roche Ltd Neurodegenerative Disease Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.5.4 F. Hoffmann-La Roche Ltd Neurodegenerative Disease Products Introduction
• 5.6 UCB SA
  • 5.6.1 UCB SA Company Profile
  • 5.6.2 UCB SA Business Overview
  • 5.6.3 UCB SA Neurodegenerative Disease Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.6.4 UCB SA Neurodegenerative Disease Products Introduction
• 5.7 Boehringer Ingelheim Group
  • 5.7.1 Boehringer Ingelheim Group Company Profile
  • 5.7.2 Boehringer Ingelheim Group Business Overview
  • 5.7.3 Boehringer Ingelheim Group Neurodegenerative Disease Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.7.4 Boehringer Ingelheim Group Neurodegenerative Disease Products Introduction
• 5.8 GlaxoSmithKline Plc
  • 5.8.1 GlaxoSmithKline Plc Company Profile
  • 5.8.2 GlaxoSmithKline Plc Business Overview
  • 5.8.3 GlaxoSmithKline Plc Neurodegenerative Disease Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.8.4 GlaxoSmithKline Plc Neurodegenerative Disease Products Introduction
• 5.9 Pfizer Inc.
  • 5.9.1 Pfizer Inc. Company Profile
  • 5.9.2 Pfizer Inc. Business Overview
  • 5.9.3 Pfizer Inc. Neurodegenerative Disease Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.9.4 Pfizer Inc. Neurodegenerative Disease Products Introduction

6 Market Analysis and Forecast, By Product Types

• 6.1 Global Neurodegenerative Disease Sales, Revenue and Market Share by Types (2015-2020)
  • 6.1.1 Global Neurodegenerative Disease Sales and Market Share by Types (2015-2020)
  • 6.1.2 Global Neurodegenerative Disease Revenue and Market Share by Types (2015-2020)
  • 6.1.3 Global Neurodegenerative Disease Price by Types (2015-2020)
• 6.2 Global Neurodegenerative Disease Market Forecast by Types (2020-2025)
  • 6.2.1 Global Neurodegenerative Disease Market Forecast Sales and Market Share by Types (2020-2025)
  • 6.2.2 Global Neurodegenerative Disease Market Forecast Revenue and Market Share by Types (2020-2025)
• 6.3 Global Neurodegenerative Disease Sales, Price and Growth Rate by Types (2015-2020)
  • 6.3.1 Global Neurodegenerative Disease Sales, Price and Growth Rate of N-methyl-D-aspartate Receptor
  • 6.3.2 Global Neurodegenerative Disease Sales, Price and Growth Rate of Selective Serotonin Reuptake Inhibitor
  • 6.3.3 Global Neurodegenerative Disease Sales, Price and Growth Rate of Dopamine Inhibitors
• 6.4 Global Neurodegenerative Disease Market Revenue and Sales Forecast, by Types (2020-2025)
  • 6.4.1 N-methyl-D-aspartate Receptor Market Revenue and Sales Forecast (2020-2025)
  • 6.4.2 Selective Serotonin Reuptake Inhibitor Market Revenue and Sales Forecast (2020-2025)
  • 6.4.3 Dopamine Inhibitors Market Revenue and Sales Forecast (2020-2025)

7 Market Analysis and Forecast, By Applications

• 7.1 Global Neurodegenerative Disease Sales, Revenue and Market Share by Applications (2015-2020)
  • 7.1.1 Global Neurodegenerative Disease Sales and Market Share by Applications (2015-2020)
  • 7.1.2 Global Neurodegenerative Disease Revenue and Market Share by Applications (2015-2020)
• 7.2 Global Neurodegenerative Disease Market Forecast by Applications (2020-2025)
  • 7.2.1 Global Neurodegenerative Disease Market Forecast Sales and Market Share by Applications (2020-2025)
  • 7.2.2 Global Neurodegenerative Disease Market Forecast Revenue and Market Share by Applications (2020-2025)
• 7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
  • 7.3.1 Global Neurodegenerative Disease Revenue, Sales and Growth Rate of Hospital (2015-2020)
  • 7.3.2 Global Neurodegenerative Disease Revenue, Sales and Growth Rate of Clinic (2015-2020)
• 7.4 Global Neurodegenerative Disease Market Revenue and Sales Forecast, by Applications (2020-2025)
  • 7.4.1 Hospital Market Revenue and Sales Forecast (2020-2025)
  • 7.4.2 Clinic Market Revenue and Sales Forecast (2020-2025)

8 Market Analysis and Forecast, By Regions

• 8.1 Global Neurodegenerative Disease Sales by Regions (2015-2020)
• 8.2 Global Neurodegenerative Disease Market Revenue by Regions (2015-2020)
• 8.3 Global Neurodegenerative Disease Market Forecast by Regions (2020-2025)

9 North America Neurodegenerative Disease Market Analysis

• 9.1 Market Overview and Prospect Analysis
• 9.2 North America Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)
• 9.3 North America Neurodegenerative Disease Market Revenue and Growth Rate (2015-2020)
• 9.4 North America Neurodegenerative Disease Market Forecast
• 9.5 The Influence of COVID-19 on North America Market
• 9.6 North America Neurodegenerative Disease Market Analysis by Country
  • 9.6.1 U.S. Neurodegenerative Disease Sales and Growth Rate
  • 9.6.2 Canada Neurodegenerative Disease Sales and Growth Rate
  • 9.6.3 Mexico Neurodegenerative Disease Sales and Growth Rate

10 Europe Neurodegenerative Disease Market Analysis

• 10.1 Market Overview and Prospect Analysis
• 10.2 Europe Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)
• 10.3 Europe Neurodegenerative Disease Market Revenue and Growth Rate (2015-2020)
• 10.4 Europe Neurodegenerative Disease Market Forecast
• 10.5 The Influence of COVID-19 on Europe Market
• 10.6 Europe Neurodegenerative Disease Market Analysis by Country
  • 10.6.1 Germany Neurodegenerative Disease Sales and Growth Rate
  • 10.6.2 United Kingdom Neurodegenerative Disease Sales and Growth Rate
  • 10.6.3 France Neurodegenerative Disease Sales and Growth Rate
  • 10.6.4 Italy Neurodegenerative Disease Sales and Growth Rate
  • 10.6.5 Spain Neurodegenerative Disease Sales and Growth Rate
  • 10.6.6 Russia Neurodegenerative Disease Sales and Growth Rate

11 Asia-Pacific Neurodegenerative Disease Market Analysis

• 11.1 Market Overview and Prospect Analysis
• 11.2 Asia-Pacific Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)
• 11.3 Asia-Pacific Neurodegenerative Disease Market Revenue and Growth Rate (2015-2020)
• 11.4 Asia-Pacific Neurodegenerative Disease Market Forecast
• 11.5 The Influence of COVID-19 on Asia Pacific Market
• 11.6 Asia-Pacific Neurodegenerative Disease Market Analysis by Country
  • 11.6.1 China Neurodegenerative Disease Sales and Growth Rate
  • 11.6.2 Japan Neurodegenerative Disease Sales and Growth Rate
  • 11.6.3 South Korea Neurodegenerative Disease Sales and Growth Rate
  • 11.6.4 Australia Neurodegenerative Disease Sales and Growth Rate
  • 11.6.5 India Neurodegenerative Disease Sales and Growth Rate

12 South America Neurodegenerative Disease Market Analysis

• 12.1 Market Overview and Prospect Analysis
• 12.2 South America Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)
• 12.3 South America Neurodegenerative Disease Market Revenue and Growth Rate (2015-2020)
• 12.4 South America Neurodegenerative Disease Market Forecast
• 12.5 The Influence of COVID-19 on South America Market
• 12.6 South America Neurodegenerative Disease Market Analysis by Country
  • 12.6.1 Brazil Neurodegenerative Disease Sales and Growth Rate
  • 12.6.2 Argentina Neurodegenerative Disease Sales and Growth Rate
  • 12.6.3 Columbia Neurodegenerative Disease Sales and Growth Rate

13 Middle East and Africa Neurodegenerative Disease Market Analysis

• 13.1 Market Overview and Prospect Analysis
• 13.2 Middle East and Africa Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)
• 13.3 Middle East and Africa Neurodegenerative Disease Market Revenue and Growth Rate (2015-2020)
• 13.4 Middle East and Africa Neurodegenerative Disease Market Forecast
• 13.5 The Influence of COVID-19 on Middle East and Africa Market
• 13.6 Middle East and Africa Neurodegenerative Disease Market Analysis by Country
  • 13.6.1 UAE Neurodegenerative Disease Sales and Growth Rate
  • 13.6.2 Egypt Neurodegenerative Disease Sales and Growth Rate
  • 13.6.3 South Africa Neurodegenerative Disease Sales and Growth Rate

14 Conclusions and Recommendations

• 14.1 Key Market Findings and Prospects
• 14.2 Advice for Investors

15 Appendix

• 15.1 Methodology
• 15.2 Research Data Source

List of Tables and Figures

Figure Product Picture

Figure Global Neurodegenerative Disease Market Size and Growth Rate 2015-2025

Table Neurodegenerative Disease Key Market Segments

Figure Global Neurodegenerative Disease Market Revenue ($) Segment by Type from 2015-2020

Figure Global Neurodegenerative Disease Market Revenue ($) Segment by Applications from 2015-2020

Table SWOT Analysis

Figure Global COVID-19 Status

Figure Supply Chain

Table Major Players Headquarters, and Service Area of Neurodegenerative Disease

Table Major Players Revenue in 2019

Figure Major Players Revenue Share in 2019

Table Merck and Co. Inc. Company Profile

Table Merck and Co. Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Merck and Co. Inc. Production and Growth Rate

Figure Merck and Co. Inc. Market Revenue ($) Market Share 2015-2020

Table AbbVie Inc. Company Profile

Table AbbVie Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure AbbVie Inc. Production and Growth Rate

Figure AbbVie Inc. Market Revenue ($) Market Share 2015-2020

Table Amneal Pharmaceuticals Inc. Company Profile

Table Amneal Pharmaceuticals Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Amneal Pharmaceuticals Inc. Production and Growth Rate

Figure Amneal Pharmaceuticals Inc. Market Revenue ($) Market Share 2015-2020

Table Teva Pharmaceutical Company Profile

Table Teva Pharmaceutical Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Teva Pharmaceutical Production and Growth Rate

Figure Teva Pharmaceutical Market Revenue ($) Market Share 2015-2020

Table F. Hoffmann-La Roche Ltd Company Profile

Table F. Hoffmann-La Roche Ltd Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure F. Hoffmann-La Roche Ltd Production and Growth Rate

Figure F. Hoffmann-La Roche Ltd Market Revenue ($) Market Share 2015-2020

Table UCB SA Company Profile

Table UCB SA Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure UCB SA Production and Growth Rate

Figure UCB SA Market Revenue ($) Market Share 2015-2020

Table Boehringer Ingelheim Group Company Profile

Table Boehringer Ingelheim Group Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Boehringer Ingelheim Group Production and Growth Rate

Figure Boehringer Ingelheim Group Market Revenue ($) Market Share 2015-2020

Table GlaxoSmithKline Plc Company Profile

Table GlaxoSmithKline Plc Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure GlaxoSmithKline Plc Production and Growth Rate

Figure GlaxoSmithKline Plc Market Revenue ($) Market Share 2015-2020

Table Pfizer Inc. Company Profile

Table Pfizer Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Pfizer Inc. Production and Growth Rate

Figure Pfizer Inc. Market Revenue ($) Market Share 2015-2020

Table Global Neurodegenerative Disease Sales by Types (2015-2020)

Table Global Neurodegenerative Disease Sales Share by Types (2015-2020)

Table Global Neurodegenerative Disease Revenue ($) by Types (2015-2020)

Table Global Neurodegenerative Disease Revenue Share by Types (2015-2020)

Table Global Neurodegenerative Disease Price ($) by Types (2015-2020)

Table Global Neurodegenerative Disease Market Forecast Sales by Types (2020-2025)

Table Global Neurodegenerative Disease Market Forecast Sales Share by Types (2020-2025)

Table Global Neurodegenerative Disease Market Forecast Revenue ($) by Types (2020-2025)

Table Global Neurodegenerative Disease Market Forecast Revenue Share by Types (2020-2025)

Figure Global N-methyl-D-aspartate Receptor Sales and Growth Rate (2015-2020)

Figure Global N-methyl-D-aspartate Receptor Price (2015-2020)

Figure Global Selective Serotonin Reuptake Inhibitor Sales and Growth Rate (2015-2020)

Figure Global Selective Serotonin Reuptake Inhibitor Price (2015-2020)

Figure Global Dopamine Inhibitors Sales and Growth Rate (2015-2020)

Figure Global Dopamine Inhibitors Price (2015-2020)

Figure Global Neurodegenerative Disease Market Revenue ($) and Growth Rate Forecast of N-methyl-D-aspartate Receptor (2020-2025)

Figure Global Neurodegenerative Disease Sales and Growth Rate Forecast of N-methyl-D-aspartate Receptor (2020-2025)

Figure Global Neurodegenerative Disease Market Revenue ($) and Growth Rate Forecast of Selective Serotonin Reuptake Inhibitor (2020-2025)

Figure Global Neurodegenerative Disease Sales and Growth Rate Forecast of Selective Serotonin Reuptake Inhibitor (2020-2025)

Figure Global Neurodegenerative Disease Market Revenue ($) and Growth Rate Forecast of Dopamine Inhibitors (2020-2025)

Figure Global Neurodegenerative Disease Sales and Growth Rate Forecast of Dopamine Inhibitors (2020-2025)

Table Global Neurodegenerative Disease Sales by Applications (2015-2020)

Table Global Neurodegenerative Disease Sales Share by Applications (2015-2020)

Table Global Neurodegenerative Disease Revenue ($) by Applications (2015-2020)

Table Global Neurodegenerative Disease Revenue Share by Applications (2015-2020)

Table Global Neurodegenerative Disease Market Forecast Sales by Applications (2020-2025)

Table Global Neurodegenerative Disease Market Forecast Sales Share by Applications (2020-2025)

Table Global Neurodegenerative Disease Market Forecast Revenue ($) by Applications (2020-2025)

Table Global Neurodegenerative Disease Market Forecast Revenue Share by Applications (2020-2025)

Figure Global Hospital Sales and Growth Rate (2015-2020)

Figure Global Hospital Price (2015-2020)

Figure Global Clinic Sales and Growth Rate (2015-2020)

Figure Global Clinic Price (2015-2020)

Figure Global Neurodegenerative Disease Market Revenue ($) and Growth Rate Forecast of Hospital (2020-2025)

Figure Global Neurodegenerative Disease Sales and Growth Rate Forecast of Hospital (2020-2025)

Figure Global Neurodegenerative Disease Market Revenue ($) and Growth Rate Forecast of Clinic (2020-2025)

Figure Global Neurodegenerative Disease Sales and Growth Rate Forecast of Clinic (2020-2025)

Figure Global Neurodegenerative Disease Sales and Growth Rate (2015-2020)

Table Global Neurodegenerative Disease Sales by Regions (2015-2020)

Table Global Neurodegenerative Disease Sales Market Share by Regions (2015-2020)

Figure Global Neurodegenerative Disease Sales Market Share by Regions in 2019

Figure Global Neurodegenerative Disease Revenue and Growth Rate (2015-2020)

Table Global Neurodegenerative Disease Revenue by Regions (2015-2020)

Table Global Neurodegenerative Disease Revenue Market Share by Regions (2015-2020)

Figure Global Neurodegenerative Disease Revenue Market Share by Regions in 2019

Table Global Neurodegenerative Disease Market Forecast Sales by Regions (2020-2025)

Table Global Neurodegenerative Disease Market Forecast Sales Share by Regions (2020-2025)

Table Global Neurodegenerative Disease Market Forecast Revenue ($) by Regions (2020-2025)

Table Global Neurodegenerative Disease Market Forecast Revenue Share by Regions (2020-2025)

Figure North America Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)

Figure North America Neurodegenerative Disease Market Revenue and Growth Rate (2015-2020)

Figure North America Neurodegenerative Disease Market Forecast Sales (2020-2025)

Figure North America Neurodegenerative Disease Market Forecast Revenue ($) (2020-2025)

Figure North America COVID-19 Status

Figure U.S. Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)

Figure Canada Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)

Figure Mexico Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)

Figure Europe Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)

Figure Europe Neurodegenerative Disease Market Revenue and Growth Rate (2015-2020)

Figure Europe Neurodegenerative Disease Market Forecast Sales (2020-2025)

Figure Europe Neurodegenerative Disease Market Forecast Revenue ($) (2020-2025)

Figure Europe COVID-19 Status

Figure Germany Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)

Figure United Kingdom Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)

Figure France Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)

Figure Italy Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)

Figure Spain Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)

Figure Russia Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)

Figure Asia-Pacific Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)

Figure Asia-Pacific Neurodegenerative Disease Market Revenue and Growth Rate (2015-2020)

Figure Asia-Pacific Neurodegenerative Disease Market Forecast Sales (2020-2025)

Figure Asia-Pacific Neurodegenerative Disease Market Forecast Revenue ($) (2020-2025)

Figure Asia Pacific COVID-19 Status

Figure China Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)

Figure Japan Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)

Figure South Korea Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)

Figure Australia Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)

Figure India Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)

Figure South America Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)

Figure South America Neurodegenerative Disease Market Revenue and Growth Rate (2015-2020)

Figure South America Neurodegenerative Disease Market Forecast Sales (2020-2025)

Figure South America Neurodegenerative Disease Market Forecast Revenue ($) (2020-2025)

Figure Brazil Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)

Figure Argentina Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)

Figure Columbia Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)

Figure Middle East and Africa Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)

Figure Middle East and Africa Neurodegenerative Disease Market Revenue and Growth Rate (2015-2020)

Figure Middle East and Africa Neurodegenerative Disease Market Forecast Sales (2020-2025)

Figure Middle East and Africa Neurodegenerative Disease Market Forecast Revenue ($) (2020-2025)

Figure UAE Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)

Figure Egypt Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)

Figure South Africa Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)